{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:51:51Z","timestamp":1793386311216,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,16]]},"DOI":"10.7759\/cureus.25998","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:30:25Z","timestamp":1655371825000},"source":"Crossref","is-referenced-by-count":19,"title":["Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment"],"prefix":"10.7759","author":[{"given":"Nailah","family":"Asif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepanjali","family":"Vedantam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani S","family":"Poman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshya","family":"Motwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.21857","article-title":"What is migraine?","volume":"327","author":"Walter K","year":"2022","unstructured":"Walter K. What is migraine?. JAMA. 2022, 327:93. 10.1001\/jama.2021.21857","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020, 396:1204-1222. 10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01941.x","article-title":"Global prevalence of chronic migraine: a systematic review","volume":"30","author":"Natoli JL","year":"2010","unstructured":"Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010, 30:599-609. 10.1111\/j.1468-2982.2009.01941.x","journal-title":"Cephalalgia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38.1-211. 10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/head.13459","article-title":"Migraine progression: a systematic review","volume":"59","author":"Buse DC","year":"2019","unstructured":"Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: a systematic review. Headache. 2019, 59:306-338. 10.1111\/head.13459","journal-title":"Headache"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001256","article-title":"Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine","volume":"84","author":"Lipton RB","year":"2015","unstructured":"Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015, 84:688-695. 10.1212\/WNL.0000000000001256","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30478-1","article-title":"Migraine","volume":"391","author":"Dodick DW","year":"2018","unstructured":"Dodick DW. Migraine. Lancet (London, England). 2018, 391:1315-1330. 10.1016\/S0140-6736(18)30478-1","journal-title":"Lancet (London, England)"},{"key":"ref8","unstructured":"Institute of Health Metrics and Evaluation. Global health data exchange (GHDx). (2019). Accessed. April 20, 2022:  http:\/\/ghdx.healthdata.org\/gbd-results-tool?params=gbd-api-2019-permalink\/d780dffbe8a381b25e1416884959e88b."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58010044","article-title":"Cognitive behavioral therapy for migraine headache: a systematic review and meta-analysis","volume":"58","author":"Bae JY","year":"2022","unstructured":"Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Cognitive behavioral therapy for migraine headache: a systematic review and meta-analysis. Medicina (Kaunas). 2022, 58:44. 10.3390\/medicina58010044","journal-title":"Medicina (Kaunas)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.344.14693","article-title":"Prevalence of migraine among patients of depressive disorder","volume":"34","author":"Jat MI","year":"2018","unstructured":"Jat MI, Afridi MI, Amar W, Lal C. Prevalence of migraine among patients of depressive disorder. Pak J Med Sci. 2018, 34:964-967. 10.12669\/pjms.344.14693","journal-title":"Pak J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40211-018-0299-5","article-title":"Migraine headache and depression in adults: a\u00a0systematic review and meta-analysis","volume":"33","author":"Amiri S","year":"2019","unstructured":"Amiri S, Behnezhad S, Azad E. Migraine headache and depression in adults: a\u00a0systematic review and meta-analysis. Neuropsychiatr. 2019, 33:131-140. 10.1007\/s40211-018-0299-5","journal-title":"Neuropsychiatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.192492","article-title":"Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers","volume":"81","author":"Buse DC","year":"2010","unstructured":"Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010, 81:428-432. 10.1136\/jnnp.2009.192492","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref13","article-title":"Migraine en depressie verdienen gezamenlijke zorg","volume":"154","author":"Louter MA","year":"2010","unstructured":"Louter MA, Veen G, Ferrari MD, Zitman FG, Terwindt GM. Migraine en depressie verdienen gezamenlijke zorg. Ned Tijdschr Geneeskd. 2010, 154:A1044.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.10.056","article-title":"Bidirectional association between migraine and depression among probands and unaffected siblings: a nationwide population-based study","volume":"279","author":"Chen MH","year":"2021","unstructured":"Chen MH, Pan TL, Lin WC, et al.. Bidirectional association between migraine and depression among probands and unaffected siblings: a nationwide population-based study. J Affect Disord. 2021, 279:687-691. 10.1016\/j.jad.2020.10.056","journal-title":"J Affect Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1017\/thg.2016.43","article-title":"Familial aggregation of migraine and depression: insights from a large Australian twin sample","volume":"19","author":"Yang Y","year":"2016","unstructured":"Yang Y, Zhao H, Heath AC, Madden PA, Martin NG, Nyholt DR. Familial aggregation of migraine and depression: insights from a large Australian twin sample. Twin Res Hum Genet. 2016, 19:312-321. 10.1017\/thg.2016.43","journal-title":"Twin Res Hum Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01425.x","article-title":"A twin study of depression and migraine: evidence for a shared genetic vulnerability","volume":"49","author":"Schur EA","year":"2009","unstructured":"Schur EA, Noonan C, Buchwald D, Goldberg J, Afari N. A twin study of depression and migraine: evidence for a shared genetic vulnerability. Headache. 2009, 49:1493-1502. 10.1111\/j.1526-4610.2009.01425.x","journal-title":"Headache"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0150-2","article-title":"Molecular genetic overlap between migraine and major depressive disorder","volume":"26","author":"Yang Y","year":"2018","unstructured":"Yang Y, Zhao H, Boomsma DI, et al.. Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet. 2018, 26:1202-1216. 10.1038\/s41431-018-0150-2","journal-title":"Eur J Hum Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap8757","article-title":"Analysis of shared heritability in common disorders of the brain","volume":"360","author":"Anttila V","year":"2018","unstructured":"Anttila V, Bulik-Sullivan B, Finucane HK, et al.. Analysis of shared heritability in common disorders of the brain. Science. 2018, 360:10.1126\/science.aap8757","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261477","article-title":"A replication study separates polymorphisms behind migraine with and without depression","volume":"16","author":"Petschner P","year":"2021","unstructured":"Petschner P, Baksa D, Hullam G, et al.. A replication study separates polymorphisms behind migraine with and without depression. PLoS One. 2021, 16:e0261477. 10.1371\/journal.pone.0261477","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2174\/0929867327666201117100026","article-title":"The association between migraine and depression based on miRNA biomarkers and cohort studies","volume":"28","author":"Chen YH","year":"2021","unstructured":"Chen YH, Wang H. The association between migraine and depression based on miRNA biomarkers and cohort studies. Curr Med Chem. 2021, 28:5648-5656. 10.2174\/0929867327666201117100026","journal-title":"Curr Med Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-013-1370-8","article-title":"Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders","volume":"133","author":"Ligthart L","year":"2014","unstructured":"Ligthart L, Hottenga JJ, Lewis CM, et al.. Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders. Hum Genet. 2014, 133:173-186. 10.1007\/s00439-013-1370-8","journal-title":"Hum Genet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-014-1471-y","article-title":"Role of cortical spreading depression in the pathophysiology of migraine","volume":"30","author":"Cui Y","year":"2014","unstructured":"Cui Y, Kataoka Y, Watanabe Y. Role of cortical spreading depression in the pathophysiology of migraine. Neurosci Bull. 2014, 30:812-822. 10.1007\/s12264-014-1471-y","journal-title":"Neurosci Bull"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410362929","article-title":"5-HTTLPR polymorphism in the serotonin transporter gene and migraine: a systematic review and meta-analysis","volume":"30","author":"Sch\u00fcrks M","year":"2010","unstructured":"Sch\u00fcrks M, Rist PM, Kurth T. 5-HTTLPR polymorphism in the serotonin transporter gene and migraine: a systematic review and meta-analysis. Cephalalgia. 2010, 30:1296-1305. 10.1177\/0333102410362929","journal-title":"Cephalalgia"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2014.11.2.192","article-title":"Genetic role of BDNF Val66Met and 5-HTTLPR polymorphisms on depressive disorder","volume":"11","author":"Lee KY","year":"2014","unstructured":"Lee KY, Jeong SH, Kim SH, et al.. Genetic role of BDNF Val66Met and 5-HTTLPR polymorphisms on depressive disorder. Psychiatry Investig. 2014, 11:192-199. 10.4306\/pi.2014.11.2.192","journal-title":"Psychiatry Investig"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01428.x","article-title":"No influence of 5-HTTLPR gene polymorphism on migraine symptomatology, comorbid depression, and chronification","volume":"50","author":"Wieser T","year":"2010","unstructured":"Wieser T, Dresler K, Evers S, et al.. No influence of 5-HTTLPR gene polymorphism on migraine symptomatology, comorbid depression, and chronification. Headache. 2010, 50:420-430. 10.1111\/j.1526-4610.2009.01428.x","journal-title":"Headache"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.11.203","article-title":"Low levels of serum serotonin and amino acids identified in migraine patients","volume":"496","author":"Ren C","year":"2018","unstructured":"Ren C, Liu J, Zhou J, et al.. Low levels of serum serotonin and amino acids identified in migraine patients. Biochem Biophys Res Commun. 2018, 496:267-273. 10.1016\/j.bbrc.2017.11.203","journal-title":"Biochem Biophys Res Commun"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.39.9.1239","article-title":"Serotonin metabolism in migraine","volume":"39","author":"Ferrari MD","year":"1989","unstructured":"Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology. 1989, 39:1239-1242. 10.1212\/wnl.39.9.1239","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0391-4","article-title":"Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels","volume":"64","author":"Rossi C","year":"2008","unstructured":"Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P. Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol. 2008, 64:1-8. 10.1007\/s00228-007-0391-4","journal-title":"Eur J Clin Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-016-0711-0","article-title":"Genetic and biochemical changes of the serotonergic system in migraine pathobiology","volume":"18","author":"Gasparini CF","year":"2017","unstructured":"Gasparini CF, Smith RA, Griffiths LR. Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J Headache Pain. 2017, 18:20. 10.1186\/s10194-016-0711-0","journal-title":"J Headache Pain"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-66","article-title":"Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis","volume":"11","author":"Samaan Z","year":"2011","unstructured":"Samaan Z, Gaysina D, Cohen-Woods S, et al.. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol. 2011, 11:66. 10.1186\/1471-2377-11-66","journal-title":"BMC Neurol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01400.x","article-title":"Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis","volume":"29","author":"Rubino E","year":"2009","unstructured":"Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia. 2009, 29:818-825. 10.1111\/j.1468-2982.2007.01400.x","journal-title":"Cephalalgia"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2015.1120327","article-title":"Association between MTHFR C677T polymorphism and depression: a meta-analysis in the Chinese population","volume":"21","author":"Jiang W","year":"2016","unstructured":"Jiang W, Xu J, Lu XJ, Sun Y. Association between MTHFR C677T polymorphism and depression: a meta-analysis in the Chinese population. Psychol Health Med. 2016, 21:675-685. 10.1080\/13548506.2015.1120327","journal-title":"Psychol Health Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0269881104047285","article-title":"The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland","volume":"18","author":"Kelly CB","year":"2004","unstructured":"Kelly CB, McDonnell AP, Johnston TG, et al.. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol. 2004, 18:567-571. 10.1177\/0269881104047285","journal-title":"J Psychopharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-008-0917-2","article-title":"Homocysteine plasma levels in patients with migraine with aura","volume":"29","author":"Moschiano F","year":"2008","unstructured":"Moschiano F, D'Amico D, Usai S, et al.. Homocysteine plasma levels in patients with migraine with aura. Neurol Sci. 2008, 29:173-175. 10.1007\/s10072-008-0917-2","journal-title":"Neurol Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01484.x","article-title":"The relationship between homocysteine and genes of folate-related enzymes in migraine patients","volume":"50","author":"Oterino A","year":"2010","unstructured":"Oterino A, Toriello M, Valle N, et al.. The relationship between homocysteine and genes of folate-related enzymes in migraine patients. Headache. 2010, 50:99-168. 10.1111\/j.1526-4610.2009.01484.x","journal-title":"Headache"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0876-9","article-title":"Exploration of intrinsic brain activity in migraine with and without comorbid depression","volume":"19","author":"Ma M","year":"2018","unstructured":"Ma M, Zhang J, Chen N, Guo J, Zhang Y, He L. Exploration of intrinsic brain activity in migraine with and without comorbid depression. J Headache Pain. 2018, 19:48. 10.1186\/s10194-018-0876-9","journal-title":"J Headache Pain"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01774.x","article-title":"A diffusion tensor magnetic resonance imaging study of corpus callosum from adult patients with migraine complicated with depressive\/anxious disorder","volume":"51","author":"Li XL","year":"2011","unstructured":"Li XL, Fang YN, Gao QC, et al.. A diffusion tensor magnetic resonance imaging study of corpus callosum from adult patients with migraine complicated with depressive\/anxious disorder. Headache. 2011, 51:237-245. 10.1111\/j.1526-4610.2010.01774.x","journal-title":"Headache"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.21037\/qims-21-667","article-title":"Identifying functional brain abnormalities in migraine and depression comorbidity","volume":"12","author":"Yang Y","year":"2022","unstructured":"Yang Y, Wei K, Zhang H, et al.. Identifying functional brain abnormalities in migraine and depression comorbidity. Quant Imaging Med Surg. 2022, 12:2288-2302. 10.21037\/qims-21-667","journal-title":"Quant Imaging Med Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.10101419","article-title":"Resting-state functional connectivity in treatment-resistant depression","volume":"168","author":"Lui S","year":"2011","unstructured":"Lui S, Wu Q, Qiu L, et al.. Resting-state functional connectivity in treatment-resistant depression. Am J Psychiatry. 2011, 168:642-648. 10.1176\/appi.ajp.2010.10101419","journal-title":"Am J Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.09.020","article-title":"Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus","volume":"62","author":"Greicius MD","year":"2007","unstructured":"Greicius MD, Flores BH, Menon V, et al.. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry. 2007, 62:429-437. 10.1016\/j.biopsych.2006.09.020","journal-title":"Biol Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac9698","article-title":"Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior","volume":"351","author":"Ferenczi EA","year":"2016","unstructured":"Ferenczi EA, Zalocusky KA, Liston C, et al.. Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science. 2016, 351:aac9698. 10.1126\/science.aac9698","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.07.003","article-title":"Frontal lobe involvement in the processing of meaningful auditory stimuli develops during childhood and adolescence","volume":"33","author":"Bender S","year":"2006","unstructured":"Bender S, Oelkers-Ax R, Resch F, Weisbrod M. Frontal lobe involvement in the processing of meaningful auditory stimuli develops during childhood and adolescence. Neuroimage. 2006, 33:759-773. 10.1016\/j.neuroimage.2006.07.003","journal-title":"Neuroimage"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.080002","article-title":"Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral grey matter abnormalities in patients with migraine","volume":"77","author":"Rocca MA","year":"2006","unstructured":"Rocca MA, Ceccarelli A, Falini A, et al.. Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral grey matter abnormalities in patients with migraine. J Neurol Neurosurg Psychiatry. 2006, 77:686-689. 10.1136\/jnnp.2005.080002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1037\/bul0000102","article-title":"Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms","volume":"143","author":"Salk RH","year":"2017","unstructured":"Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol Bull. 2017, 143:783-822. 10.1037\/bul0000102","journal-title":"Psychol Bull"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00309.x","article-title":"Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I","volume":"46","author":"Martin VT","year":"2006","unstructured":"Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I. Headache. 2006, 46:3-23. 10.1111\/j.1526-4610.2006.00309.x","journal-title":"Headache"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-009-0066-1","article-title":"The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen","volume":"13","author":"Peterlin BL","year":"2009","unstructured":"Peterlin BL, Katsnelson MJ, Calhoun AH. The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen. Curr Pain Headache Rep. 2009, 13:404-412. 10.1007\/s11916-009-0066-1","journal-title":"Curr Pain Headache Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1177\/03331024090290S303","article-title":"Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine)","volume":"29","author":"Dodick DW","year":"2009","unstructured":"Dodick DW. Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine). Cephalalgia. 2009, 29:7-14. 10.1177\/03331024090290S303","journal-title":"Cephalalgia"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002057","article-title":"The contribution of stress to the comorbidity of migraine and major depression: results from a prospective cohort study","volume":"3","author":"Swanson SA","year":"2013","unstructured":"Swanson SA, Zeng Y, Weeks M, Colman I. The contribution of stress to the comorbidity of migraine and major depression: results from a prospective cohort study. BMJ Open. 2013, 3:e002057. 10.1136\/bmjopen-2012-002057","journal-title":"BMJ Open"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000271383.60376.67","article-title":"History of childhood maltreatment is associated with comorbid depression in women with migraine","volume":"69","author":"Tietjen GE","year":"2007","unstructured":"Tietjen GE, Brandes JL, Digre KB, et al.. History of childhood maltreatment is associated with comorbid depression in women with migraine. Neurology. 2007, 69:959-968. 10.1212\/01.wnl.0000271383.60376.67","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00810.x","article-title":"Depression and anxiety: effect on the migraine-obesity relationship","volume":"47","author":"Tietjen GE","year":"2007","unstructured":"Tietjen GE, Peterlin BL, Brandes JL, et al.. Depression and anxiety: effect on the migraine-obesity relationship. Headache. 2007, 47:866-875. 10.1111\/j.1526-4610.2007.00810.x","journal-title":"Headache"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00993.x","article-title":"Comorbidity of migraine and psychiatric disorders--a national population-based study","volume":"48","author":"Jette N","year":"2008","unstructured":"Jette N, Patten S, Williams J, Becker W, Wiebe S. Comorbidity of migraine and psychiatric disorders--a national population-based study. Headache. 2008, 48:501-516. 10.1111\/j.1526-4610.2007.00993.x","journal-title":"Headache"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.06.019","article-title":"Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study","volume":"146","author":"Heckman BD","year":"2009","unstructured":"Heckman BD, Holroyd KA, Himawan L, O'Donnell FJ, Tietjen G, Utley C, Stillman M. Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study. Pain. 2009, 146:56-64. 10.1016\/j.pain.2009.06.019","journal-title":"Pain"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.09.010","article-title":"Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management","volume":"118","author":"Lant\u00e9ri-Minet M","year":"2005","unstructured":"Lant\u00e9ri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain. 2005, 118:319-326. 10.1016\/j.pain.2005.09.010","journal-title":"Pain"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000297192.84581.21","article-title":"Impact of comorbidity on headache-related disability","volume":"70","author":"Saunders K","year":"2008","unstructured":"Saunders K, Merikangas K, Low NC, Von Korff M, Kessler RC. Impact of comorbidity on headache-related disability. Neurology. 2008, 70:538-547. 10.1212\/01.wnl.0000297192.84581.21","journal-title":"Neurology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1177\/0972753120929563","article-title":"Migraine disability, quality of life, and its predictors","volume":"27","author":"Pradeep R","year":"2020","unstructured":"Pradeep R, Nemichandra SC, Harsha S, Radhika K. Migraine disability, quality of life, and its predictors. Ann Neurosci. 2020, 27:18-23. 10.1177\/0972753120929563","journal-title":"Ann Neurosci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-68","article-title":"The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study","volume":"15","author":"Kim SY","year":"2014","unstructured":"Kim SY, Park SP. The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study. J Headache Pain. 2014, 15:68. 10.1186\/1129-2377-15-68","journal-title":"J Headache Pain"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-012-0479-9","article-title":"Depression and risk of transformation of episodic to chronic migraine","volume":"13","author":"Ashina S","year":"2012","unstructured":"Ashina S, Serrano D, Lipton RB, et al.. Depression and risk of transformation of episodic to chronic migraine. J Headache Pain. 2012, 13:615-624. 10.1007\/s10194-012-0479-9","journal-title":"J Headache Pain"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199754564.001.0001","article-title":"The Migraine Brain: Imaging Structure and Function","author":"Borsook D","year":"2012","unstructured":"Borsook D, May A, Goadsby PJ, Hargreaves R. The Migraine Brain: Imaging Structure and Function. Borsook D (ed): Oxford University Press, 2012. 10.1093\/acprof:oso\/9780199754564.001.0001"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128087","article-title":"The impacts of migraine among outpatients with major depressive disorder at a two-year follow-up","volume":"10","author":"Hung CI","year":"2015","unstructured":"Hung CI, Liu CY, Yang CH, Wang SJ. The impacts of migraine among outpatients with major depressive disorder at a two-year follow-up. PLoS One. 2015, 10:e0128087. 10.1371\/journal.pone.0128087","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413485658","article-title":"The international classification of headache disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013, 33:629-808. 10.1177\/0333102413485658","journal-title":"Cephalalgia"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.07.002","article-title":"Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status","volume":"155","author":"Westergaard ML","year":"2014","unstructured":"Westergaard ML, Gl\u00fcmer C, Hansen EH, Jensen RH. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014, 155:2005-2013. 10.1016\/j.pain.2014.07.002","journal-title":"Pain"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.08.018","article-title":"Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag Health Studies","volume":"153","author":"Hagen K","year":"2012","unstructured":"Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag Health Studies. Pain. 2012, 153:56-61. 10.1016\/j.pain.2011.08.018","journal-title":"Pain"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2018-002048","article-title":"Medication-overuse headache","volume":"19","author":"Wakerley BR","year":"2019","unstructured":"Wakerley BR. Medication-overuse headache. Pract Neurol. 2019, 19:399-403. 10.1136\/practneurol-2018-002048","journal-title":"Pract Neurol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.05.025","article-title":"A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine","volume":"110","author":"Keskinbora K","year":"2008","unstructured":"Keskinbora K, Aydinli I. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Clin Neurol Neurosurg. 2008, 110:979-984. 10.1016\/j.clineuro.2008.05.025","journal-title":"Clin Neurol Neurosurg"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1999.3901028.x","article-title":"Selective serotonin reuptake inhibitors for migraine prophylaxis","volume":"39","author":"Landy S","year":"1999","unstructured":"Landy S, McGinnis J, Curlin D, Laizure SC. Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache. 1999, 39:28-32. 10.1046\/j.1526-4610.1999.3901028.x","journal-title":"Headache"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1159\/000080960","article-title":"Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache","volume":"50","author":"Rampello L","year":"2004","unstructured":"Rampello L, Alvano A, Chiechio S, Malaguarnera M, Raffaele R, Vecchio I, Nicoletti F. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology. 2004, 50:322-328. 10.1159\/000080960","journal-title":"Neuropsychobiology"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182189d70","article-title":"Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study","volume":"31","author":"MacGregor EA","year":"2011","unstructured":"MacGregor EA, Frith AA, Hackshaw A. Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study. J Clin Psychopharmacol. 2011, 31:375-401. 10.1097\/JCP.0b013e3182189d70","journal-title":"J Clin Psychopharmacol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-013-1376-y","article-title":"Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder","volume":"34","author":"Curone M","year":"2013","unstructured":"Curone M, Tullo V, Savino M, Proietti-Cecchini A, Bussone G, D'Amico D. Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder. Neurol Sci. 2013, 34:175-177. 10.1007\/s10072-013-1376-y","journal-title":"Neurol Sci"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0912","article-title":"An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache","volume":"69","author":"Volpe FM","year":"2008","unstructured":"Volpe FM. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry. 2008, 69:1449-1454. 10.4088\/jcp.v69n0912","journal-title":"J Clin Psychiatry"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1998.tb04098.x","article-title":"Treatment of hyperfunctional lines of the face with botulinum toxin A","volume":"24","author":"Binder WJ","year":"1998","unstructured":"Binder WJ, Blitzer A, Brin MF. Treatment of hyperfunctional lines of the face with botulinum toxin A. Dermatol Surg. 1998, 24:1198-1205. 10.1111\/j.1524-4725.1998.tb04098.x","journal-title":"Dermatol Surg"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S113614","article-title":"Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations","volume":"10","author":"Barbanti P","year":"2017","unstructured":"Barbanti P, Ferroni P. Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations. J Pain Res. 2017, 10:2319-2329. 10.2147\/JPR.S113614","journal-title":"J Pain Res"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S70456","article-title":"Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: an open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety","volume":"8","author":"Boudreau GP","year":"2015","unstructured":"Boudreau GP, Grosberg BM, McAllister PJ, Lipton RB, Buse DC. Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: an open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety. Int J Gen Med. 2015, 8:79-86. 10.2147\/IJGM.S70456","journal-title":"Int J Gen Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2016.1196687","article-title":"Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study","volume":"127","author":"Zhang H","year":"2017","unstructured":"Zhang H, Zhang H, Wei Y, Lian Y, Chen Y, Zheng Y. Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study. Int J Neurosci. 2017, 127:285-290. 10.1080\/00207454.2016.1196687","journal-title":"Int J Neurosci"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00678","article-title":"Response predictors in chronic migraine: medication overuse and depressive symptoms negatively impact onabotulinumtoxin-A treatment","volume":"10","author":"Schiano di Cola F","year":"2019","unstructured":"Schiano di Cola F, Caratozzolo S, Liberini P, Rao R, Padovani A. Response predictors in chronic migraine: medication overuse and depressive symptoms negatively impact onabotulinumtoxin-A treatment. Front Neurol. 2019, 10:678. 10.3389\/fneur.2019.00678","journal-title":"Front Neurol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.5812\/archneurosci.58028","article-title":"Effectiveness of mindfulness-based cognitive-behavioral therapy on relieving migraine headaches","volume":"4","author":"Mansourishad H","year":"2017","unstructured":"Mansourishad H, Togha M, Borjali A, Karimi R. Effectiveness of mindfulness-based cognitive-behavioral therapy on relieving migraine headaches. Arch Neurosci. 2017, 4:e58028. 10.5812\/archneurosci.58028","journal-title":"Arch Neurosci"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016670","article-title":"Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components","volume":"7","author":"Probyn K","year":"2017","unstructured":"Probyn K, Bowers H, Mistry D, et al.. Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components. BMJ Open. 2017, 7:e016670. 10.1136\/bmjopen-2017-016670","journal-title":"BMJ Open"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2015.07.005","article-title":"Cognitive behavior therapy for comorbid migraine and\/or tension-type headache and major depressive disorder: an exploratory randomized controlled trial","volume":"73","author":"Martin PR","year":"2015","unstructured":"Martin PR, Aiello R, Gilson K, Meadows G, Milgrom J, Reece J. Cognitive behavior therapy for comorbid migraine and\/or tension-type headache and major depressive disorder: an exploratory randomized controlled trial. Behav Res Ther. 2015, 73:8-18. 10.1016\/j.brat.2015.07.005","journal-title":"Behav Res Ther"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012295.pub2","article-title":"Psychological therapies for the prevention of migraine in adults","volume":"7","author":"Sharpe L","year":"2019","unstructured":"Sharpe L, Dudeney J, Williams AC, et al.. Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev. 2019, 7:CD012295. 10.1002\/14651858.CD012295.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2020-102088","article-title":"Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study","volume":"46","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Huang Y, Li H, et al.. Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study. Reg Anesth Pain Med. 2021, 46:145-150. 10.1136\/rapm-2020-102088","journal-title":"Reg Anesth Pain Med"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2019.10.019","article-title":"Vagus nerve stimulation and depression","volume":"48","author":"Senova S","year":"2019","unstructured":"Senova S, Rabu C, Beaumont S, Michel V, Palfi S, Mallet L, Domenech P. Vagus nerve stimulation and depression. Presse Med. 2019, 48:1507-1519. 10.1016\/j.lpm.2019.10.019","journal-title":"Presse Med"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0537-8","article-title":"Vagal nerve stimulation for treatment-resistant depression","volume":"14","author":"Carreno FR","year":"2017","unstructured":"Carreno FR, Frazer A. Vagal nerve stimulation for treatment-resistant depression. Neurotherapeutics. 2017, 14:716-727. 10.1007\/s13311-017-0537-8","journal-title":"Neurotherapeutics"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0542-4","article-title":"Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study","volume":"16","author":"Barbanti P","year":"2015","unstructured":"Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E, Bussone G. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain. 2015, 16:61. 10.1186\/s10194-015-0542-4","journal-title":"J Headache Pain"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-009-0073-3","article-title":"Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data","volume":"30","author":"Cecchini AP","year":"2009","unstructured":"Cecchini AP, Mea E, Tullo V, et al.. Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci. 2009, 30:101-104. 10.1007\/s10072-009-0073-3","journal-title":"Neurol Sci"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho TW","year":"2010","unstructured":"Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010, 6:573-582. 10.1038\/nrneurol.2010.127","journal-title":"Nat Rev Neurol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4853","article-title":"Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial","volume":"319","author":"Dodick DW","year":"2018","unstructured":"Dodick DW, Silberstein SD, Bigal ME, et al.. Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial. JAMA. 2018, 319:1999-2008. 10.1001\/jama.2018.4853","journal-title":"JAMA"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709038","article-title":"Fremanezumab for the preventive treatment of chronic migraine","volume":"377","author":"Silberstein SD","year":"2017","unstructured":"Silberstein SD, Dodick DW, Bigal ME, et al.. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med. 2017, 377:2113-2122. 10.1056\/NEJMoa1709038","journal-title":"N Engl J Med"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00249-5","article-title":"Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study","volume":"14","author":"Bigal ME","year":"2015","unstructured":"Bigal ME, Dodick DW, Rapoport AM, et al.. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol. 2015, 14:1081-1090. 10.1016\/S1474-4422(15)00249-5","journal-title":"Lancet Neurol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010600","article-title":"Long-term safety, tolerability, and efficacy of fremanezumab in migraine: a randomized study","volume":"95","author":"Goadsby PJ","year":"2020","unstructured":"Goadsby PJ, Silberstein SD, Yeung PP, Cohen JM, Ning X, Yang R, Dodick DW. Long-term safety, tolerability, and efficacy of fremanezumab in migraine: a randomized study. Neurology. 2020, 95:2487-2499. 10.1212\/WNL.0000000000010600","journal-title":"Neurology"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1111\/head.14097","article-title":"Effects of fremanezumab in patients with chronic migraine and comorbid depression: subgroup analysis of the randomized HALO CM study","volume":"61","author":"Lipton RB","year":"2021","unstructured":"Lipton RB, Cohen JM, Galic M, et al.. Effects of fremanezumab in patients with chronic migraine and comorbid depression: subgroup analysis of the randomized HALO CM study. Headache. 2021, 61:662-672. 10.1111\/head.14097","journal-title":"Headache"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/head.13970","article-title":"Efficacy of galcanezumab for migraine prevention in patients with a medical history of anxiety and\/or depression: a post hoc analysis of the phase 3, randomized, double-blind, placebo-controlled REGAIN, and pooled EVOLVE-1 and EVOLVE-2 studies","volume":"60","author":"Smitherman TA","year":"2020","unstructured":"Smitherman TA, Tietjen GE, Schuh K, Skljarevski V, Lipsius S, D'Souza DN, Pearlman EM. Efficacy of galcanezumab for migraine prevention in patients with a medical history of anxiety and\/or depression: a post hoc analysis of the phase 3, randomized, double-blind, placebo-controlled REGAIN, and pooled EVOLVE-1 and EVOLVE-2 studies. Headache. 2020, 60:2202-2219. 10.1111\/head.13970","journal-title":"Headache"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach H","year":"1991","unstructured":"Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991, 148:705-713. 10.1176\/ajp.148.6.705","journal-title":"Am J Psychiatry"},{"key":"ref92","article-title":"The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports","volume":"9","author":"Evans RW","year":"2007","unstructured":"Evans RW. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. MedGenMed. 2007, 9:48.","journal-title":"MedGenMed"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01691.x","article-title":"The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper","volume":"50","author":"Evans RW","year":"2010","unstructured":"Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache. 2010, 50:1089-1099. 10.1111\/j.1526-4610.2010.01691.x","journal-title":"Headache"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.5144","article-title":"Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome","volume":"75","author":"Orlova Y","year":"2018","unstructured":"Orlova Y, Rizzoli P, Loder E. Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol. 2018, 75:566-572. 10.1001\/jamaneurol.2017.5144","journal-title":"JAMA Neurol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-02946-8","article-title":"Drug interaction between a selective serotonin reuptake inhibitor and a triptan leading to serotonin toxicity: a case report and review of the literature","volume":"15","author":"Jin G","year":"2021","unstructured":"Jin G, Stokes P. Drug interaction between a selective serotonin reuptake inhibitor and a triptan leading to serotonin toxicity: a case report and review of the literature. J Med Case Rep. 2021, 15:371. 10.1186\/s13256-021-02946-8","journal-title":"J Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100496-migraine-with-comorbid-depression-pathogenesis-clinical-implications-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:45:54Z","timestamp":1707489954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100496-migraine-with-comorbid-depression-pathogenesis-clinical-implications-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":95,"URL":"https:\/\/doi.org\/10.7759\/cureus.25998","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,16]]}}}